An observational study in End of Life, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-24.
Sponsored by University Hospital, Strasbourg, France · Observational
80% of patients wish to die at home. The number of deaths will increase in the coming years due to the aging population. The general practitioner (GP) is at the center of this care. Despite national plans for the development of palliative care, dying at home remains complicated. The difficulties described and known are organizational (workload) and linked to the doctor's experience with the suffering of the patient and their family. Many studies have been conducted in hospital settings, and the solutions developed are often not very accessible to GP. Conducting a study on this subject will allow us to take stock of this outpatient care provided by general practitioners following numerous changes that have occurred in recent years, both in terms of palliative care teaching and in terms of modifications to the care offered.
456 studies on the registry are indexed under Death; 86 are open to participants now.
This study's planned enrollment of 12 is below the median of 400 across 236 observational studies indexed under Death.
Browse Death studies →University Hospital, Strasbourg, France is the lead sponsor of 999 studies on the registry; 358 are open to participants now.
Counted across the registry records on this site, refreshed daily.
General physician based in Bas-Rhin agreeing to participate in the research
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Identify barriers to outpatient care for terminally ill palliative patients by general practitioners in the Bas Rhin region.
Time frame: At 8 months
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Strasbourg, France →